Steris (STE) Long-Term Debt Issuances (2021)
Steris' (STE) quarterly Long-Term Debt Issuances came in at -$700.0 million in Q3 2021, down 151.85% quarter-over-quarter from $1.4 billion in Q2 2021.
Steris (STE) Long-Term Debt Issuances (2021) Analysis & Trends
Steris' Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at -$700.0 million for Q3 2021.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to -$700.0 million in Q3 2021; TTM through Jun 2022 was -$700.0 million, a 136.84% decrease from a year earlier, with the FY2022 full-year figure at $650.0 million, up 18.18% from the prior year.
- Long-Term Debt Issuances declined to -$700.0 million in Q3 2021 per STE's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $1.4 billion in Q2 2021 and bottomed at -$700.0 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.71 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -700.00 Mn |
| Sep 30, 2021 | -700.00 Mn |
| Jun 30, 2021 | 1.35 Bn |
| Jun 30, 2021 | 1.35 Bn |
| Mar 31, 2021 | 550.00 Mn |
| Mar 31, 2021 | 550.00 Mn |